Patrick Johnson, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    AstraZeneca
    Topic: 
    CLL
    Date added: 
    08/04/2022
    Relationship end date: 
    11/30/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Seagen
    Topic: 
    Hodgkin lymphoma
    Date added: 
    08/04/2022
    Relationship end date: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    ADC Therapeutics
    Topic: 
    Diffuse large B-cell lymphoma
    Date added: 
    08/04/2022
    Relationship end date: 
    08/31/2022
Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies